Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
intramuscular injection
|
| gptkbp:clinicalTrialPhase |
gptkb:Phase_I
Phase II |
| gptkbp:contains |
Ebola virus glycoprotein gene
chimpanzee adenovirus type 3 vector |
| gptkbp:developedBy |
gptkb:National_Institutes_of_Health
2014 GlaxoSmithKline |
| https://www.w3.org/2000/01/rdf-schema#label |
cAd3-ZEBOV
|
| gptkbp:immunogenicity |
induces immune response against Ebola virus
|
| gptkbp:relatedTo |
gptkb:rVSV-ZEBOV
|
| gptkbp:safetyProfile |
well-tolerated in clinical trials
|
| gptkbp:target |
gptkb:Ebola_virus_disease
|
| gptkbp:testedBy |
gptkb:Gabon
gptkb:Guinea gptkb:Kenya gptkb:Liberia gptkb:Mali gptkb:Senegal gptkb:Sierra_Leone gptkb:Switzerland gptkb:Uganda gptkb:United_Kingdom gptkb:United_States |
| gptkbp:bfsParent |
gptkb:ChAd3-EBO-Z
|
| gptkbp:bfsLayer |
7
|